Becker's Healthcare October 23, 2025
Elizabeth Casolo

Coverage for drugs recently approved by the FDA can take months to solidify, according to the Institute for Clinical and Economic Review’s “Launch Price and Access Report,” published Oct. 23.

Researchers reviewed 24 drugs from Boston-based Tufts Medical Center’s specialty drug evidence and coverage database, including information on specialty drug coverage decisions from up to 18 commercial health plans.

The study found some coverage policies took several months, sometimes up to a year, after FDA approval to address the majority of these drugs. As of December 2024, drugs approved in the first six months of the year were more likely to have policies...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma, Pharma / Biotech
What’s new with GLP-1s
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
283: A candid conversation: Physicians on the front lines of GLP‑1 care
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model
Q&A: New PQA Resource Highlights 40 Projects Targeting Social Determinants of Health

Share Article